期刊文献+

唐氏中孕血清学筛查标本-20℃保存1年后结果比对与临床可接受性评价 被引量:2

Comparing the review result about the samples of serum screening test for the Downs syndromes in pregnancy have been staying in Minus 20 degrees Celsius for one year and evaluating the clinical acceptability
下载PDF
导出
摘要 目的研究唐氏血清学筛查标本在-20℃条件下保存1年的临床可接受性。方法检测-20℃冰箱保存1年后的中孕期唐氏血清学筛查标本的甲胎蛋白(α-fetoprotein,AFP)、游离人绒毛膜促性腺激素(freeβ-human chorionic gonadotrophin,β-hCG)、游离雌三醇(unconjugated oestriol,uE3)的浓度,与原始浓度进行统计学分析,验证储存条件改变后,3种标志物的浓度是否满足标准要求。结果复查结果与原始结果无显著性差异,临床可以接受。结论-20℃保存唐氏血清学标本可以代替-80℃保存,复查结果可满足临床要求。 Objective To study the clinical acceptability about the samples of serum screening test for the Downs syndromes in pregnancy have been staying in Minus 20 degrees Celsius for one year. Method Test again the α-fetoprotein,free β-human chorionic Gonadotrophin and unconjugated oestriol concentration in the specimen of serum screening test for the Downs syndromes in pregnancy have been staying in Minus 20 degrees Celsius for one year.The results of the review were statistically analyzed with the original results,then verify the requirements are met whether or not when the storage conditions were changed. Results There was no significant difference between the review results and the original results,which was clinically acceptable. Conclusions The review results can meet the clinical requirements when Storage conditions by Minus 20 degrees Celsius to Minus 80 degrees Celsius.
作者 冉健 裴元元 胡亮 温丽娟 魏凤香 RAN Jian;PEI Yuan-yuan;HU Liang
出处 《中国产前诊断杂志(电子版)》 2019年第1期31-33,共3页 Chinese Journal of Prenatal Diagnosis(Electronic Version)
基金 龙岗区科技计划项目(2016060714160728)
关键词 唐氏筛查 甲胎蛋白 游离人绒毛膜促性腺激素 游离雌三醇 线性回归分析 Downs syndrome screening α-fetoprotein freeβ-human chorionic gonadotrophin unconjugated oestriol linear regression analysis
  • 相关文献

参考文献6

二级参考文献26

  • 1Wright De.提高产前筛查质量:英国的经验[J].中国产前诊断杂志(电子版),2010(4):51-51. 被引量:2
  • 2吴楠,王宏志.132例智力低下患儿的病因学调查及细胞遗传学研究[J].中国优生与遗传杂志,2006,14(9):42-42. 被引量:6
  • 3李松滨.医学遗传学[M].第一版,人民卫生出版社,2001.88-99.
  • 4de Haan JB,Wolvetang EJ,Cristiano F,et al.Reactive oxygen species and their contribution to pathology in down syndrome[J].Adv Pharmacol,1997,38:379-402.
  • 5Simonian N A,Coyle JT.Oxidative stress in neurodegenerative disease[J].Annu Rev Pharmacol Toxicol,1996,36:83-106.
  • 6陆国书,杜传书,李巍,等.产前遗传病诊断[M].广州:广东科技出版社.2002.265-266.
  • 7左彶.医学遗传学[M].第4版.北京:人民卫生出版社.2004.182-184.
  • 8National Committee for Clinical Laboratory Standards.EP9-A Method comparison and bias estimation using patient samples[S].Wayne,PA:NCCLS.1995.
  • 9U.S.Department of Health and Human Services.Medicare,medicaid and CLIA program:regulations implementing the clinical laboratory lmprovement amendment of 1988 (CLIA).Final rule[S].Fed Regist,1992,57:7002-7186.
  • 10International Organization for Standardization.General Requirements for the Competence of Testing and Calibration Laboratories.ISO/IEC 17025,International Organization for Standardization,Geneva,1999.

共引文献184

同被引文献23

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部